CVS Health CEO Lynch steps down as the drug-store chain struggles to right its path
CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year and the health-care giant struggling on several fronts. CVS Health also warned of disappointing third-quarter earnings and said investors should not rely on guidance it laid out in August.
In addition to Joyner taking over as president and CEO, current Chairman of the Board Roger Farah will now become the board’s ...
CVS Health shares are trading lower by 3.8% during Tuesday's session. Health insurer stocks are down after UnitedHealth ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The pharmacy industry is in crisis. That's especially true at CVS, where layoffs are piling on top of layoffs — and the future of the company is in question. CVS Health announced this month that ...
Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...
CVS Health named David Joyner as its new chief, succeeding Karen Lynch at the helm of the struggling healthcare giant ...
By Danielle Kaye CVS Health abruptly ousted its chief executive, Karen S. Lynch, on Friday as the pharmacy and health ...
CVS also released its projections for the company’s upcoming third quarter, saying it expects adjusted earnings of between $1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback